InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+14.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by White Ted, Chairman & CEO. Director active across 1 company, notably Verrica Pharmaceuticals Inc.. Aggregated, 11 filings have been logged. Breakdown: 4 buys · 3 sells. Total volume traded: €460k. Activity tracked since 4 June 2021. The latest transaction was filed on 24 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
150,000 shares0Common StockSEC:0001415889-25-003231:0
24,979 shares@ US$2.6612.9% of flowCommon StockSEC:0001415889-24-022423:0
32,469 shares@ US$7.0645.7% of flowCommon StockSEC:0001415889-24-019976:0
112,500 shares0Common StockSEC:0001415889-24-008538:0
22,141 shares@ US$2.9313.2% of flowCommon StockSEC:0001209191-23-055528:0
75,000 shares0Common StockSEC:0001209191-23-047523:0
150,000 shares0Common StockSEC:0001209191-23-043297:0
7,500 shares@ US$2.103.3% of flowCommon StockSEC:0001209191-23-011127:0
Ideal exit: 1 Apr 2023 (T+270)
23,809 shares@ US$2.1010.6% of flowCommon StockSEC:0001209191-22-040608:0
Ideal exit: 1 Apr 2023 (T+270)
4,000 shares@ US$9.950.030% mcap50.0% of flowCommon StockSEC:0001209191-21-038482:0
Ideal exit: 1 Mar 2022 (T+270)
4,000 shares@ US$9.957.1% of flowCommon StockSEC:0001209191-21-038482
Ideal exit: 1 Mar 2022 (T+270)
11 of 11 declarations
About White Ted
Ted White is the President and CEO of Verrica Pharmaceuticals Inc. He is responsible for the overall direction of the company, including strategy and operations. White brings significant expertise in the pharmaceutical sector.
